Solara Active Pharma Sciences Limited (SOLARA.NS)
INR 509.35
(2.82%)
INR 509.35
(2.82%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 23.46 Billion INR | -19.06% |
| 2022 | 28.99 Billion INR | -1.81% |
| 2021 | 29.52 Billion INR | 12.97% |
| 2020 | 26.13 Billion INR | 21.36% |
| 2019 | 21.53 Billion INR | 9.87% |
| 2018 | 19.6 Billion INR | 7.6% |
| 2017 | 18.21 Billion INR | 18215230.0% |
| 2016 | 100 Thousand INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 22.89 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 23.46 Billion INR | -19.06% |
| 2023 Q4 | 23.46 Billion INR | 0.0% |
| 2023 Q2 | 28.75 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 28.66 Billion INR | 0.0% |
| 2022 FY | 28.99 Billion INR | -1.81% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 28.99 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 29.52 Billion INR | 12.97% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 30.54 Billion INR | 0.0% |
| 2021 Q4 | 29.52 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 26.13 Billion INR | 21.36% |
| 2020 Q4 | 26.13 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 25.36 Billion INR | 0.0% |
| 2019 Q2 | 20.81 Billion INR | 0.0% |
| 2019 FY | 21.53 Billion INR | 9.87% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 21.53 Billion INR | 24.11% |
| 2019 Q3 | 17.35 Billion INR | -16.63% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 19.6 Billion INR | 7.6% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 18.5 Billion INR | 0.0% |
| 2018 Q4 | 19.6 Billion INR | 0.0% |
| 2017 Q4 | 18.21 Billion INR | 9.31% |
| 2017 Q3 | 16.66 Billion INR | 0.0% |
| 2017 FY | 18.21 Billion INR | 18215230.0% |
| 2016 FY | 100 Thousand INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarti Drugs Limited | 24.32 Billion INR | 3.526% |
| Albert David Limited | 4.97 Billion INR | -371.213% |
| Alembic Limited | 23.28 Billion INR | -0.766% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -4883.996% |
| Hester Biosciences Limited | 6.62 Billion INR | -254.286% |
| Hikal Limited | 24.87 Billion INR | 5.651% |
| Ind-Swift Limited | 6.54 Billion INR | -258.549% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -877.499% |
| Unichem Laboratories Limited | 31.69 Billion INR | 25.959% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 63.594% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -1488.959% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -206.694% |
| Brooks Laboratories Limited | 904.45 Million INR | -2494.493% |
| Eris Lifesciences Limited | 70.48 Billion INR | 66.709% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -980.994% |
| Wanbury Limited | 3.43 Billion INR | -583.158% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 9.12% |
| Alkem Laboratories Limited | 155.74 Billion INR | 84.933% |
| FDC Limited | 24.68 Billion INR | 4.922% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 17.675% |
| Gufic Biosciences Limited | 10.92 Billion INR | -114.784% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -101.407% |
| Innova Captab Limited | 13.2 Billion INR | -77.654% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -4.554% |
| Ipca Laboratories Limited | 111.01 Billion INR | 78.862% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 79.68% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -235.09% |
| Lupin Limited | 239.97 Billion INR | 90.221% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -603.788% |
| Medico Remedies Limited | 961.95 Million INR | -2339.412% |
| Morepen Laboratories Limited | 12.93 Billion INR | -81.456% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -7.099% |
| Orchid Pharma Limited | 15.53 Billion INR | -51.016% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -195.408% |
| RPG Life Sciences Limited | 5.12 Billion INR | -357.543% |
| Sigachi Industries Limited | 6.94 Billion INR | -238.051% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 97.254% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -4.104% |
| Themis Medicare Limited | 5.66 Billion INR | -314.289% |
| Vaishali Pharma Limited | 799.55 Million INR | -2834.875% |
| Venus Remedies Limited | 6.26 Billion INR | -274.36% |
| Windlas Biotech Limited | 6.26 Billion INR | -274.733% |
| ZIM Laboratories Limited | 4.46 Billion INR | -425.175% |
| Sakar Healthcare Limited | 3.88 Billion INR | -503.768% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 94.794% |
| Divi's Laboratories Limited | 154.7 Billion INR | 84.831% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -117.675% |
| Mankind Pharma Limited | 119.63 Billion INR | 80.385% |
| Sequent Scientific Limited | 15.4 Billion INR | -52.339% |
| Laurus Labs Limited | 83.87 Billion INR | 72.021% |
| Neuland Laboratories Limited | 18.32 Billion INR | -28.05% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 41.249% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 83.657% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 91.986% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -539.626% |
| Wockhardt Limited | 76.49 Billion INR | 69.321% |
| Bal Pharma Limited | 3.2 Billion INR | -632.422% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 93.945% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -93.316% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -2209.393% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | 13.004% |
| Shilpa Medicare Limited | 30.93 Billion INR | 24.137% |
| Valiant Laboratories Limited | 3.42 Billion INR | -584.764% |
| Ajanta Pharma Limited | 46.38 Billion INR | 49.409% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -669.397% |
| Granules India Limited | 55.2 Billion INR | 57.497% |
| Medicamen Biotech Limited | 2.94 Billion INR | -696.748% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -479.889% |
| Piramal Enterprises Limited | 826.05 Billion INR | 97.159% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 84.419% |
| NATCO Pharma Limited | 69.06 Billion INR | 66.022% |
| Suven Life Sciences Limited | 2.84 Billion INR | -723.65% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -1217.022% |
| Strides Pharma Science Limited | 58.39 Billion INR | 59.817% |
| Indoco Remedies Limited | 21.44 Billion INR | -9.412% |
| Alpa Laboratories Limited | 1.82 Billion INR | -1184.951% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -1455.392% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -355.615% |